Augmented drug preferentially eliminates cancer cells but does not harm healthy cells
Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type of targeted approach a "prodrug" -; a medicine designed to release its payload in a particular area of the body and in no other areas.
Pavel Majer Barbara Slusher Emily Henderson Jonathan Powell Johns Hopkins Drug Discovery Program Johns Hopkins Kimmel Cancer Center
Source: news-medical.net